ursolic acid has been researched along with Bone Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, P; Fu, D; Ji, X; Li, G; Ni, Z; Shang, X; Wu, K | 1 |
| Chang, IL; Chen, HY; Cheng, CH; Chueh, PJ; Hsieh, CP; Lee, YH; Wu, CC | 1 |
| Chen, QZ; Deng, ZL; He, BC; Li, Y; Liu, Y; Nian, W; Tian, DD; Zhang, RX; Zhou, LY; Zou, X | 1 |
3 other study(ies) available for ursolic acid and Bone Neoplasms
| Article | Year |
|---|---|
A novel redox-responsive ursolic acid polymeric prodrug delivery system for osteosarcoma therapy.
Topics: Animals; Antineoplastic Agents, Phytogenic; Bone Neoplasms; Cell Line, Tumor; Drug Delivery Systems; Humans; Mice; Micelles; Osteosarcoma; Oxidation-Reduction; Polyethylene Glycols; Polymers; Prodrugs; Stimuli Responsive Polymers; Triterpenes; Ursolic Acid; Xenograft Model Antitumor Assays | 2021 |
Ursolic Acid Triggers Apoptosis in Human Osteosarcoma Cells via Caspase Activation and the ERK1/2 MAPK Pathway.
Topics: Apoptosis; Bone Neoplasms; Caspase 3; Caspase 8; Caspase 9; Cell Line, Tumor; Humans; MAP Kinase Signaling System; Mitogen-Activated Protein Kinases; Osteosarcoma; Triterpenes; Ursolic Acid | 2016 |
Ursolic acid inhibits proliferation and induces apoptosis by inactivating Wnt/β-catenin signaling in human osteosarcoma cells.
Topics: Animals; Antineoplastic Agents, Phytogenic; Apoptosis; beta Catenin; Blotting, Western; Bone Neoplasms; Cell Proliferation; Female; Humans; Immunoenzyme Techniques; Mice; Mice, Nude; Osteosarcoma; Reverse Transcriptase Polymerase Chain Reaction; Signal Transduction; Triterpenes; Tumor Cells, Cultured; Ursolic Acid; Wnt Signaling Pathway; Xenograft Model Antitumor Assays | 2016 |